Chugai believes that a culture of respect for human rights is a cornerstone for a company to be recognized as a member of society and to earn trust. Therefore, we declare our respect for human rights in the Chugai Group Code of Conduct, which are based on our shared Core Values. We recognize Chugai’s responsibility for respecting the human rights of all people involved in our business activities, and with our deep involvement in people’s lives and health as a member of the healthcare industry, we are promoting measures with a greater awareness of respect for human rights.
Chugai Group Human Rights Statement
Chugai Group’s mission is to dedicate ourselves to adding value by creating and delivering innovative products and services for the medical community and human health around the world. Under its business philosophy, i.e., “Innovation all for the patients,” the Chugai Group contributes to society through the provision of innovative new drugs and solutions.
Chugai Group will work to implement management that respects human rights and to realize a society that respects human rights in order for us to grow together with society now and in the future, to become a company, which is truly trusted and fully supported by all stakeholders.
- Basic Policy on Respect for Human Rights
Chugai Group respects and supports the International Bill of Human Rights (Universal Declaration of Human Rights and International Covenants on Human Rights), the ILO Declaration on Fundamental Principles and Rights at Work and other international norms. Moreover, it respects and protects the human rights of patients and test subjects in compliance with the Ethical Principles for Medical Research Involving Human Subjects (Declaration of Helsinki) in the research and development of pharmaceutical products.
Furthermore, the Group hereby sets forth Chugai Group Human Rights Policy based on the UN Guiding Principles on Business and Human Rights (UNGPs) to promote activities for the respect of human rights. The policy is based on the Chugai Group Mission Statement and promises activities for the further respect of human rights.
- Scope of application
This policy applies to all board members and employees of the Chugai Group. Also, we seek understanding and support for this policy from our business partners, and work for the respect of human rights together.
- Responsibility to respect human rights
Chugai Group recognizes that its business activities may directly or indirectly affect human rights and fulfills its responsibility for the respect of human rights by not infringing the human rights of affected people and taking appropriate measures for correction in case its business activity may cause an adverse impact on human rights.
Also in case an adverse impact on human rights caused by our business partners is suspected to be associated with business, products and services of Chugai Group, we ask the business partners to respect human rights and not infringe.
- Education and training
Chugai Group will continuously implement appropriate human rights education based on UNGPs for its board members and employees.
- Human rights due diligence
Chugai Group, in accordance with the UN Guiding Principles on Business and Human Rights, will conduct precautionary surveys to have an understanding for the prevention and mitigation of adverse impact on human rights that the company may give to society. The company will further establish and continuously implement a system of human rights due diligence that enables proper and effective remedial measures in case a problem is found.
In case it becomes clear that Chugai Group causes an adverse impact on human rights in its business activities, we will work on the remedy through appropriate procedures.
- Dialog and discussion
Chugai Group, in implementing the initiatives under the policy, will positively use external expertise on human rights, consider the situation of the people affected by our business activities, recognize the importance of understanding things from the viewpoint of affected people and sincerely conduct appropriate dialog and discussions with stakeholders.
- Compliance with applicable laws and regulations
Chugai Group will comply with the applicable laws and regulations in all countries and regions where it operates. Moreover, the Group will work to respect–to the maximum extent possible–the international principles on human rights.
- Disclosure of information
Chugai Group will disclose the progress and results of its activities on human rights on its website and other formats.
Established on January 29, 2019
Creating a Corporate Culture of Respect for Self and Others
We work to establish workplaces where co-workers value each other based on an organizational climate of respect for self and others.
Among the guidelines for conduct included in the CCC are items that emphasize the importance of respect for human rights and promotion of diversity. Chugai’s corporate culture is based on respect for self and others. It is a culture in which individual employees have strong self-esteem, and in which, as diverse individuals interact with one another, they recognize each other’s values and promote respect for diversity—in short, we work to create workplaces that are free from harassment and infringement of human rights, and where co-workers value each other.
A corporate culture that respects human rights allows diverse individuals to make the most of their capabilities, thus improving performance. Moreover, by raising awareness of human rights and by promoting respect for diversity within Chugai, such a culture helps eliminate discrimination and infringement of human rights in the broader society as Chugai interacts with the public and through the everyday lives of its people.
Creating Workplaces Free from Harassment
In addition to establishing CCC hotline as a consultation service, we have assigned area counselors at each regional management office, plant, and research laboratory, giving employees someone familiar with whom they can consult.
The Chugai Group strives to foster respect for diverse personalities and values, to create workplaces where both male and female employees can work with enthusiasm and peace of mind. Accordingly, to prevent sexual harassment and power harassment (abuse of power) in the workplace, we take various measures to educate employees and raise their awareness about these issues, including distributing a sexual harassment prevention handbook to every employee, and working from a handbook on creating workplaces free from power harassment in training for managers. Additionally, under amendments to the law that took effect on January 1, 2017, business owners are now required to have in place measures to prevent harassment of employees who are pregnant or have given birth, or who take child or family care leave. Based on those changes, the Chugai Group has revised its employment regulations and harassment prevention rules, which now prohibit unfavorable treatment of employees for use of our programs for maternity, have given birth, child care and family care leave, as well as behavior that creates a hostile work environment for such employees.
We have established CCC hotline in the company, enabling employees to discuss their concerns freely, and have also established the external consultation service. Moreover, we have assigned area counselors at each regional management office, plant, and research laboratory, giving employees someone familiar with whom they can consult. Harassment consultation training by outside instructors and CCC hotline personnel is provided regularly for these area counselors and human resource managers to reinforce the knowledge and skills necessary to respond to calls.
We are conducting harassment prevention workshops for managers in each department.
We have been conducting the more practical harassment prevention workshops including maternity harassment and others for managers in each department. We have also incorporated the harassment prevention program into human resources workshops for newly appointed managers. We are aiming to foster harassment-free workplaces where people can work with enthusiasm through these efforts.
Conduct of Clinical Trials
Clinical trials are strictly conducted in accordance with global standards, respecting the rights of trial subjects and closely monitoring for patient safety based on high ethical standards.
Clinical trials are essential for verifying the safety and efficacy of investigational products, and they must be performed with respect for the rights of trial subjects. At Chugai, clinical trials are closely monitored for patient safety, following stringent scientific methodology based on the highest ethical standards and scientific standards.
The Chugai Group has created standardized procedural manuals based on Japan’s Pharmaceutical and Medical Devices Act and other related legislation, as well as on the current revision of the Declaration of Helsinki*1 and ICH-GCP*2, which are global standards. We are committed to evaluating the true value of investigational products using well-established, reputable testing procedures.
Plans for clinical trials are first drafted by experts in fields such as medicine, statistics, and safety. The actual trials are implemented based on a written plan that has been fully reviewed both internally and by outside medical institutions to ensure that it is ethically and scientifically sound. Once a trial has begun, information on safety is promptly collected and analyzed, and when necessary, that information is shared with regulatory authorities and the medical institutions involved, ensuring that patient welfare always remains the highest priority. The quality of clinical trials is also carefully managed, with a variety of steps in place to ensure the reliability of trial results.
- *1.The “Ethical Principles for Medical Research Involving Human Subjects” first adopted at the World Medical Association in 1964. Biomedical research must ultimately include testing on human subjects in order to contribute to healthcare. The 1964 Declaration of Helsinki is the ethical foundation of modern clinical trials. (Source: The Pharmaceutical Society of Japan)
- *2.Good Clinical Practice (GCP) guidelines adopted by the International Conference on Harmonisation (ICH) for conducting pharmaceutical clinical trials in the European Union, the United States and Japan.
(Source: The Pharmaceuticals and Medical Devices Agency)